SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Poseida Therapeutics, Inc. Buyout

Wilmington, Delaware--(Newsfile Corp. - November 26, 2024) - Rigrodsky Law, P.A. is investigating Poseida Therapeutics, Inc. ("Poseida") (NASDAQ: PSTX) regarding possible breaches of fiduciary duties and other violations of law related to Poseida's agreement to be acquired by Roche Holdings, Inc. Under the terms of the agreement, Poseida shareholders will receive $9.00 per share in cash, plus a non-tradeable contingent value right to receive certain contingent payments of up to an aggregate of $4.00 per share in cash upon achievement of specific milestones.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-poseida-therapeutics-inc.

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231428